Literature DB >> 1078637

Serotonin-sensitive adenylate cyclase activity of immature rat brain.

K von Hungen, S Roberts, D F Hill.   

Abstract

Cell-free preparations from superior and inferior colliculi of very young rats (1-3 days old) contained adenylate cyclase systems which were highly responsive to serotonin. The response to serotonin declined markedly during early development and was very low at maturity. Adenylate cyclase activity in the 10,000 times g particulate fraction from colliculi of newborn rats was significantly stimulated by 0.05 muM serotonin. Half-maximal activation was produced with less than 1 muM serotonin. Maximal stimulation of collicular adenylate cyclase was about 80% above basal enzyme activity and occurred with approximately 50 muM serotonin. Tryptamine and several derivatives of serotonin produced responses which were comparable to that obtained with serotonin; 5-methoxytryptamine was uniformly the most active compound tested. Norepinephrine or dopamine produced much smaller increases in adenylate cyclase activity. Stimulation of collicular adenylate cyclase by serotonin was significantly but incompletely blocked by serotonin antagonists, including d-lysergic acid diethylamide (d-LSD), 2-bromo-d-lysergic acid diethylamide, methysergide, 1-methyl-8 beta-carbobenzyloxy-aminomethyl-10 alpha-ergoline and cyproheptadine. Chlorpromazine also produced partial blockade. In contrast, l-lysergic acid diethylamide, haloperidol, propranolol, phenoxybenzamine and morphine were ineffective as serotonin blocking agents. Of the compounds which produced a partial blockage of serotonin action, d-LSD, cyproheptadine and chlorpromazine were themselves capable of stimulating adenylate cyclase activity. These results are consisent with the existence of multiple receptors in rat brain which are capable of interacting with indoleamines.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1078637     DOI: 10.1016/0006-8993(75)90980-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  16 in total

1.  Receptive communication in late-stage Rett syndrome: a cautionary note.

Authors:  K A Meyer; C H Kennedy; S Shukla; L S Cushing
Journal:  J Autism Dev Disord       Date:  1999-02

2.  Lack of involvement of dopaminergic and GABA neurones in the inhbitory effect of harmaline on the activity of striatal cholinergic neurones in the rat.

Authors:  F Javoy; C Euvrard; A Herbet; J Bockaert; A Enjalbert; Y Agid; J Glowinski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-04       Impact factor: 3.000

3.  Central serotonin receptors: effector systems, physiological roles and regulation.

Authors:  P J Conn; E Sanders-Bush
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Comment on "Asperger syndrome: Familial, pre- and perinatal factors" by Gillberg and Cederland.

Authors:  Eileen Nicole Simon
Journal:  J Autism Dev Disord       Date:  2006-02

5.  Proteins of the synaptic membrane.

Authors:  H R Mahler
Journal:  Neurochem Res       Date:  1977-04       Impact factor: 3.996

6.  Metoclopramide antagonism of 5-hydroxytryptophan-induced "wet-dog" shake behaviour in the rat.

Authors:  J R Fozard; M G Palfreyman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-06       Impact factor: 3.000

7.  Aminergic neurons: state control and plasticity in three model systems.

Authors:  C Flicker; R W McCarley; J A Hobson
Journal:  Cell Mol Neurobiol       Date:  1981-06       Impact factor: 5.046

8.  Purification and reconstitution of serotonin receptors from bovine brain.

Authors:  T K Gallaher; H H Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

9.  In vivo increase in hypothalamic cyclic AMP following 5-hydroxytryptophan administration in rats.

Authors:  M C Bundman; R A Browning
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

10.  Paradoxical decrease of brain 5-HT turnover by metergoline, a central 5-HT receptor blocker.

Authors:  S Bourgoin; F Artaud; J Bockaert; F Héry; J Glowinski; M Hamon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.